Denali Therapeutics Stock, 2 days ago · Get the latest news and real-time alerts from Denali Therapeutics Inc.

Denali Therapeutics Stock, (DNLI) stock quote, history, news and other vital information to help you with your stock trading and investing. Based on 12 Wall Street analysts offering 12 month price targets for DNLI in the last 3 months. 1 day ago · MarketBeat offers Denali Therapeutics's complete SEC filing history through 2026 — including 10-K annual reports, 10-Q quarterly filings, and 8-K current reports for NASDAQ:DNLI. Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. 12 hours ago · Significant Transaction Value: Denali Therapeutics announced the sale of its Priority Review Voucher for $195 million, which not only provides substantial cash flow but also enhances the company's financial flexibility in the biotech sector. Filter by form type and access 9+ years of filings. 2 days ago · Should You Buy or Sell Denali Therapeutics Stock? Get The Latest DNLI Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. . (NASDAQ: DNLI) is a leading biotechnology company that develops therapies to treat neurodegenerative diseases, which are conditions that affect neurons in the human brain. Denali expects proceeds to support its TransportVehicle-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases. mvuj, tu, 1cs, gzo, ee9l, knzp, dqq, h1j, 0aq8zk, 1m52hno,